Results

Total Results: 270 records

Showing results for "irritability".

21. Management of Infantile Hemangioma | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/infantile-hemangioma/policymaker
    June 21, 2016 - Clinically important harms of steroids--some of which may be short lived--included Cushingoid facies, irritability

22. Management of Infantile Hemangioma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_clinician.pdf
    June 01, 2016 - steroids were associated with harms — some of which may be short lived — such as Cushingoid facies, irritability … clinically important adverse effects, including Cushingoid facies, growth retardation, mood changes/ irritability

23. Management of Infantile Hemangioma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_policymaker.pdf
    June 01, 2016 - Clinically important harms of steroids—some of which may be short lived—included Cushingoid facies, irritability

24. Medical and Sensory-Related Therapies for Children with Autism Spectrum Disorder-An Update | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/autism-medical-update/research-protocol
    February 16, 2016 - Food and Drug Administration (FDA) for treatment of irritability and challenging behaviors in ASD ( Table … What are the effects on commonly associated symptoms (e.g., motor, medical, mood/anxiety, irritability … longer-term effects (>6 months) on commonly associated symptoms (e.g., motor, medical, mood/anxiety, irritability … What are the effects on commonly associated symptoms (e.g., motor, medical, mood/anxiety, irritability … longer-term effects (>6 months) on commonly associated symptoms (e.g., motor, medical, mood/anxiety, irritability

25. Untitled (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-medical-update_research-protocol.pdf
    February 16, 2016 - Food and Drug Administration (FDA) for treatment of irritability and challenging behaviors in ASD (Table … b)   What are the effects on commonly associated symptoms (e.g., motor, medical, mood/anxiety, irritability … longer-term effects (>6 months) on commonly associated symptoms (e.g., motor, medical, mood/anxiety, irritability … b)   What are the effects on commonly associated symptoms (e.g., motor, medical, mood/anxiety, irritability … longer-term effects (>6 months) on commonly associated symptoms (e.g., motor, medical, mood/anxiety, irritability

26. Genitourinary Syndrome of Menopause (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/genitourinary-syndrome-key-questions.pdf
    January 01, 2021 - Genitourinary Syndrome of Menopause 1 Title: Genitourinary Syndrome of Menopause The Patient-Centered Outcomes Research Institute (PCORI) is partnering with the Agency for Healthcare Research and Quality (AHRQ) to develop a systematic evidence review on Genitourinary Syndrome of Menopause. The Amer…

27. Future Research Needs for First- and Second-Generation Antipsychotics for Children and Young Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-future_research.pdf
    February 01, 2012 - Adults and children (10–17 years) Adjunctive treatment of major depressive disorder Adults Irritability … and adolescents (13–17 years) Bipolar disorder (manic/mixed) Adults and adolescents (10–17 years) Irritability … nervosa; and behavioral symptoms, including aggression, agitation, anxiety, behavioral dyscontrol, irritability … Drug Administration (FDA) approved risperidone in 2006 and aripiprazole in 2009 for the treatment of irritability … that antipsychotics are used with increasing frequency among youth for behavioral symptoms such as irritability

28. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0477_11-01-2011.pdf
    January 01, 2011 - Effective Health Care Topic Number: 0396 Document Completion Date: 05-10-12 1 Results of Topic Selection Process & Next Steps  Fibromyalgia treatment will go forward for refinement as a systematic review. The scope of this topic, including populations, interventions, comparators, and outcomes…

29. Effectiveness and Safety of Bronchial Thermoplasty in Management of Asthma: Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-202-bronchial-thermoplasty-asthma.pdf
    December 01, 2017 - Effectiveness and Safety of Bronchial Thermoplasty in Management of Asthma: Evidence Summary Comparative Effectiveness Review Number 202 Effectiveness and Safety of Bronchial Thermoplasty in Management of Asthma Evidence Summary Objectives and Rationale for Review This report summarizes a systematic review, “E…

30. Topic Brief: Ultraviolet Light for COVID-19 (pdf file)
    effectivehealthcare.ahrq.gov/system/files/docs/uv_light_covid-19-topic_brief.pdf
    December 10, 2020 - Topic Brief: Ultraviolet Light for COVID-19 1 Topic Brief: Ultraviolet Light for COVID-19 Date: 12/09/2020 Nomination Number: 0942 Purpose: This document summarizes the information addressing a nomination submitted on August 1, 2020 through the Effective Health Care Website. This information was used …

31. Noncyclic Chronic Pelvic Pain Therapies for Women: Comparative Effectiveness | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/pelvic-pain/research
    January 31, 2012 - Current Page Topic Timeline Jul. 21, 2009 Topic Suggestion Oct. 19, 2010 Research Protocol Jan. 31, 2012 Systematic Review May. 31, 2012 Disposition of Comments Report Oct. 31, 2015 Surveillance Report Noncyclic Chronic Pelvic Pain Therapies for Women: Comparative Effectiveness Systematic Review Archived January 3…

32. Glaucoma-Treatment-Appendices-11-5-10-2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment-appendices-11-5-10-2.pdf
    October 27, 2009 - Bradycardia • Vasovagal attack • Palpitations • orthostatic episode • Insomnia • dream disturbances • irritability

33. Evaluation of Effectiveness and Safety of Antiepileptic Medications in Patients with Epilepsy | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/epilepsy-medicine/research-protocol
    July 01, 2010 - Current Page Topic Timeline Mar. 10, 2008 Topic Suggestion Jul. 1, 2010 Research Protocol Dec. 21, 2011 Systematic Review Apr. 30, 2012 Disposition of Comments Report Jul. 3, 2013 Surveillance Report Evaluation of Effectiveness and Safety of Antiepileptic Medications in Patients with Epilepsy Research Protocol Arc…

34. Topic Suggestion Description | Effective Health Care Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/pin-the-area-of-autism-research-the-vast-majority-of-clinical-trials-conducted-to-date-have-addressed-only-the-questions-of-how-an-individual-treatment-compares-to-a-placebo-extremely-few-studies-have-been-conducted-that-make
    April 09, 2009 - examples of projects that are needed: For individuals with ASD who present with severe aggression and irritability

35. Autism-Adolescents Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-adolescents_surveillance.pdf
    July 01, 2014 - Brief report: retrospective case series of oxcarbazepine for irritability/agitation symptoms in autism … Brief report: retrospective case series of oxcarbazepine for irritability/agitation symptoms in autism … Reduction in irritability, compulsion and self-injurious behavior reported with antipsychotics (Risperidone … Reduction in irritability, compulsion and self-injurious behavior reported with antipsychotics (Risperidone

36. Treating Disruptive Behavior Disorders in Children and Teens | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/disruptive-behavior-disorder/consumer
    August 31, 2016 - heart rate Feeling tired or sleepy Nausea and vomiting Stomach ache Trouble falling asleep Irritability

37. Treating Disruptive Behavior Disorders in Children and Teens (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_consumer.pdf
    August 01, 2016 - heart rate ��Feeling tired or sleepy ��Nausea and vomiting ��Stomach ache ��Trouble falling asleep �� Irritability

38. Topic 0484 Treatments for Fecal Incontinence NSD FINAL SJ (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0572-140408.pdf
    January 09, 2014 - Topic 0484 Treatments for Fecal Incontinence NSD FINAL SJ § Comparative effectiveness of treatments of fecal incontinence in women- Nomination Summary Document …

39. Emerging Approaches to Diagnosis and Treatment of Non–Muscle-Invasive Bladder Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/bladder-cancer-non-muscle-invasive/research
    October 27, 2015 - Current Page Topic Timeline Oct. 3, 2012 Topic Suggestion Jul. 21, 2014 Research Protocol Oct. 27, 2015 Systematic Review Feb. 15, 2016 Disposition of Comments Report Emerging Approaches to Diagnosis and Treatment of Non–Muscle-Invasive Bladder Cancer Systematic Review Archived October 27, 2015 Web Version [NLM Si…

40. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0262_05-11-2007.pdf
    January 01, 2007 - Effective Health Care Topic Number(s): 0111 Document Completion Date: 5-19-09 1 Results of Topic Selection Process & Next Steps  Urinary incontinence will go forward for refinement as an update to or expansion of an existing comparative effectiveness or effectiveness review. The scope of thi…